Use of O2microtechniques for assessment of hormone effects on isolated endocrine cells.
D000818:Animals; D003338:Corpus Luteum / Q000378:metabolism; D004702:Endocrine Glands / Q000378:metabolism*; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005934:Glucagon / Q000494:pharmacology; D006107:Granulosa Cells / Q000201:enzymology / Q000378:metabolism; D006454:Hemoglobins / Q000032:analysis; D006728:Hormones / Q000494:pharmacology*; D007515:Islets of Langerhans / Q000378:metabolism; D007985:Leydig Cells / Q000201:enzymology; D007986:Luteinizing Hormone / Q000494:pharmacology; D008297:Male; D008365:Manometry / Q000295:instrumentation; D008832:Microchemistry; D010053:Ovary / Q000378:metabolism; D010101:Oxygen Consumption; D051381:Rats; D013053:Spectrophotometry / Q000295:instrumentation; D013385:Succinate Dehydrogenase / Q000378:metabolism
D006454:Hemoglobins; D006728:Hormones; D007986:Luteinizing Hormone; D005934:Glucagon; D013385:Succinate Dehydrogenase; D004837:Epinephrine